SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-030165
Filing Date
2018-05-22
Accepted
2018-05-22 07:00:33
Documents
3
Period of Report
2018-05-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv494744_8k.htm 8-K 19673
2 EXHIBIT 99.1 tv494744_ex99-1.htm EX-99.1 10437
3 GRAPHIC image_004.jpg GRAPHIC 5595
  Complete submission text file 0001144204-18-030165.txt   39458
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 18851272
SIC: 2834 Pharmaceutical Preparations